atazanavir sulfate has been researched along with cyclosporine in 2 studies
Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
---|---|---|---|---|---|
1,102 | 246 | 590 | 30,547 | 3,802 | 6,558 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukushima, K; Haraya, K; Ito, Y; Sugioka, N; Takada, K; Terasaka, S | 1 |
Bow, DA; Chiou, WJ; de Morais, SM; Kikuchi, R; Li, X; Voorman, RL | 1 |
2 other study(ies) available for atazanavir sulfate and cyclosporine
Article | Year |
---|---|
Long-term pharmacokinetic efficacy and safety of low-dose ritonavir as a booster and atazanavir pharmaceutical formulation based on solid dispersion system in rats.
Topics: Animals; Anti-HIV Agents; Area Under Curve; Atazanavir Sulfate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Blotting, Western; Chemistry, Pharmaceutical; Cyclosporine; Cytochrome P-450 CYP3A; Dosage Forms; Half-Life; Immunosuppressive Agents; Male; Oligopeptides; Pyridines; Rats; Rats, Wistar; Ritonavir; Spectrophotometry, Ultraviolet | 2008 |
In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia.
Topics: Antirheumatic Agents; Atazanavir Sulfate; Bilirubin; Carbamates; Cyclosporine; Furans; Glucuronosyltransferase; HIV Protease Inhibitors; Hyperbilirubinemia; In Vitro Techniques; Indinavir; Liver-Specific Organic Anion Transporter 1; Oligopeptides; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Pyridines; Rifampin; Rifamycins; Saquinavir; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfonamides | 2014 |